Purchase Order HT942525PE012
Award Date 8/22/25
Potential Completion Date 3/21/26
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lowell, MA 01852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
24
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency (DHA) awarded a Small Business Technology Transfer (STTR) Phase II contract to Emergingdx Inc., a small business subchapter S corporation based in Lowell, Massachusetts. The $1,299,985.23 Firm Fixed Price contract, which is set aside for total small business, supports the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." This contract builds upon earlier SBIR Phase I exploratory research and aims to advance innovative...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
- The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
- This is a firm fixed price SBIR Phase I contract awarded by the Department of the Navy Secretary of the Navy Office of Naval Research to Emergingdx Inc., a for-profit subchapter S corporation. The $239,636.00 contract funds research under the SBIR Program to advance disease detection and precision medicine capabilities. Emergingdx Inc. has also received several other recent SBIR and STTR Phase I awards from the Defense Health Agency and Department of Agriculture to develop biosensors, microRNA...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25 million SBIR Phase II contract to Dxlab Inc., a small business based in Somerville, Massachusetts, on June 7, 2024. Under this firm fixed-price purchase order, Dxlab will develop a portable and rugged infection diagnostic platform designed to deliver rapid, clinically actionable pathogen detection capabilities at deployed military locations and treatment facilities. The contract is designated as a Total Small Business set aside and...
- The Defense Health Agency has awarded a $249,962.26 Small Business Innovation Research (SBIR) Phase I contract to Applied Nanotech, Inc., doing business as Fepet, for the development of MicroBeID, a point-of-care, electronics-free molecular diagnostic platform for microbial detection. The contract, issued as a firm fixed-price purchase order with an ultimate completion date of March 21, 2026, is designated as a total small business set-aside and supports medical research and development...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
- The Defense Health Agency (DHA) has awarded a $249,848.78 Small Business Innovation Research (SBIR) Phase I contract to Baebies, Inc., a Durham, North Carolina-based medical diagnostic technology company. The contract, awarded on March 3, 2025, with an ultimate completion date of December 15, 2025, is designated as a Total Small Business set-aside and structured as a firm fixed-price purchase order. Under this phase of the SBIR program, Baebies will develop a wide multiplexing, multifunctional...
- This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...